Home/Filings/4/0001477449-24-000048
4//SEC Filing

Napolitano Richard J 4

Accession 0001477449-24-000048

CIK 0001477449other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:11 PM ET

Size

35.1 KB

Accession

0001477449-24-000048

Insider Transaction Report

Form 4
Period: 2024-03-01
Napolitano Richard J
Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-01+1,60413,353 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+50413,857 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+1,48115,338 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+33715,675 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+56516,240 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+89417,134 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+4,70821,842 total
  • Sale

    Common Stock

    2024-03-04$14.52/sh3,765$54,65318,077 total
  • Award

    Performance Stock Units

    2024-03-01+4,8144,814 total
    Common Stock (4,814 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-011,6043,210 total
    Common Stock (1,604 underlying)
  • Award

    Performance Stock Units

    2024-03-01+1,5151,515 total
    Common Stock (1,515 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-015041,011 total
    Common Stock (504 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-011,4812,963 total
    Common Stock (1,481 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-013371,348 total
    Common Stock (337 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-015652,260 total
    Common Stock (565 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-018944,472 total
    Common Stock (894 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-014,7089,418 total
    Common Stock (4,708 underlying)
Footnotes (13)
  • [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F10]On March 1, 2022, the reporting person was granted 4,043 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F11]On April 1, 2022, the reporting person was granted 6,778 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F12]On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F13]On March 3, 2023, the reporting person was granted 14,126 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  • [F4]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
  • [F5]Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
  • [F6]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F7]On March 1, 2024, the reporting person earned 4,614 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F8]On March 1, 2024, the reporting person earned 1,515 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F9]On May 1, 2023, the reporting person was granted 4,444 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Issuer

Teladoc Health, Inc.

CIK 0001477449

Entity typeother

Related Parties

1
  • filerCIK 0001599417

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:11 PM ET
Size
35.1 KB